CLC bio, a QIAGEN company (NASDAQ:QGEN)(FWB:QIA), today announced in collaboration with Korilog the release of the KLAST plug-in for CLC Genomics Workbench and CLC Main Workbench to accelerate the ...
New innovative product launches at American Association for Cancer Research (AACR) Annual Meeting add to broad portfolio of NGS solutions High-speed QIAxpert accelerates quantification and quality ...
It strengthens QIAGEN’s rapidly emerging portfolio of “universal” products that can be used with any NGS sequencer as well as providing a key element to the portfolio of automated solutions for the ...
QIAGEN CLC Genomics Workbench is a powerful solution to analyze and visualize next generation sequencing (NGS) data. Powered by cutting-edge technology and accelerated algorithms, it supports a ...
Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...
“Adoption of QIAGEN's universal bioinformatics solutions is growing rapidly as we continue to integrate and expand the capabilities of our applications and knowledge bases from CLC bio, Ingenuity and ...
In this webinar, we will present QIAGEN CLC Genomics Workbench and its utility for bacterial isolate identification, strain discrimination using core genome multi-locus typing (cgMLST) and detailed ...
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications. QIAGEN ...
CLC Cancer Research Workbench is the world's first comprehensive, user-friendly and customizable cancer-focused NGS bioinformatics solution QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback